AMLX
Amylyx Pharmaceuticals, Inc.After hours26.85−0.63 −2.29%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 27.21 +1.34%
Open
27.49
Prev close
27.48
Day range
26.8027.69
52-week range
10.8341.14
Volume
1.06M0.45×
Mkt cap
3.37B
P/E ttm
—
Fwd P/E
-23.38
EPS ttm
-1.41
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−34.74%
AMLX earnings and estimates
AMLX Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 5
Before the open
EPS consensus
$−0.37
range −0.42 – −0.33
EPS growth vs year ago
−1.4%
year ago −0.37
Revenue consensus
$37.82K
0.0% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±7.4%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 6, 2026 BMO | −0.39 | −0.36 | −9.04% | $0 | +10.7% | +6.9% |
| Mar '26 | May 7, 2026 BMO | −0.37 | −0.34 | −8.71% | $0 | −5.4% | −9.2% |
| Dec '25 | Mar 3, 2026 BMO | −0.30 | −0.34 | +12.23% | $0 | −7.8% | −6.5% |
| Sep '25 | Nov 6, 2025 BMO | −0.37 | −0.43 | +13.93% | $0 | −5.9% | −6.9% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.37 | −0.42−0.33 | −1.4% | $37.82K | 0.0% | −0.37 0.0% | −0.33 −12.1% | 2 / 4 |
| Next quarter Dec 2026 | −0.37 | −0.41−0.26 | −22.1% | $−37.82K | 0.0% | −0.37 0.0% | −0.34 −7.2% | 4 / 3 |
| Current year Dec 2026 | −1.50 | −1.60−1.37 | +2.1% | $0 | 0.0% | −1.50 0.0% | −1.38 −8.1% | 2 / 4 |
| Next year Dec 2027 | −1.15 | −1.700.70 | +23.3% | $28.23M | 0.0% | −1.15 +0.5% | −1.27 +9.3% | 3 / 3 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.38 | −0.40−0.35 | 4 | 0 / 0 |
| Dec 2026 | −0.37 | −0.41−0.34 | 3 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −1.48 | −1.57−1.42 | 5 | 0 / 0 |
| Dec 2027 | −1.40 | −1.63−1.20 | 4 | 0 / 0 |
| Dec 2028 | −0.97 | — | 1 | 0 / 0 |
| Dec 2029 | 3.22 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.